Alumni community member
The research of Xinnate´s co-founder at Lund University has resulted in proprietary platform technology within advanced wound care, which consists of specific peptides appearing in nature’s host defense. The company has developed a lead candidate that is currently in clinical trials for inflammatory skin diseases.
Did you know?
The body’s natural defence to promote healing is the secret in Xinnate´s gel.